Literature DB >> 27173295

Analysis of interleukin 19 serum levels and single nucleotide polymorphisms in systemic lupus erythematosus.

J R Lin1, H H Qin1, Y Wang1, J Liang1, J H Xu1.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that affects multiple organs and diminishes a patients' quality of life. It has been suggested that interleukin 19 (IL-19) is engaged in intercellular signal transduction, which is related to the immune response and the local inflammatory reaction. Single nucleotide polymorphisms (SNPs) have been used to explore the genetic basis underlying the pathogenesis of SLE. In this study, we investigated the potential correlation between the functional IL19 SNP rs2243188 and SLE. The frequency of allele C in rs2243188 was lower in the SLE population, particularly when the dominant inheritance model was applied. There was also a significant difference in the allele C frequency between the lupus nephritis (LN) and non-LN groups in both the dominant and recessive inheritance models. In addition, we identified significant differences in the serum IL-19 levels between the different classes of SLE. Although this study is still at the preliminary stage, the correlations between the IL19 SNP and SLE, and between the IL-19 levels and the different subclasses of SLE provide a reference for further exploration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27173295     DOI: 10.4238/gmr.15028007

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  2 in total

1.  Correlation of serum levels of HIF-1α and IL-19 with the disease progression of COPD: a retrospective study.

Authors:  Biaoxue Rong; Yufang Liu; Min Li; Tian Fu; Wenlong Gao; Hua Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-21

2.  Association of BCL2 polymorphisms and the IL19 single nucleotide polymorphism rs2243188 with systemic lupus erythematosus.

Authors:  Weijie Wang; Xinchang Wang; Kepeng Yang; Yongsheng Fan
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.